These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 14608525

  • 1. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
    Huggins CE, Domenighetti AA, Pedrazzini T, Pepe S, Delbridge LM.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):186-90. PubMed ID: 14608525
    [Abstract] [Full Text] [Related]

  • 2. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
    Domenighetti AA, Boixel C, Cefai D, Abriel H, Pedrazzini T.
    J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
    [Abstract] [Full Text] [Related]

  • 3. Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression.
    van den Brink OW, Delbridge LM, Pedrazzini T, Rosenfeldt FL, Pepe S.
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):153-9. PubMed ID: 18205093
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
    du Toit EF, Nabben M, Lochner A.
    Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
    [Abstract] [Full Text] [Related]

  • 8. Cardiac renin-angiotensin system: role in development of pressure-overload hypertrophy.
    Lorell BH.
    Can J Cardiol; 1995 Aug; 11 Suppl F():7F-12F. PubMed ID: 7664219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy.
    Yang XP, Samaja M, English E, Benatti P, Tarantola M, Cardace G, Motterlini R, Micheletti R, Bianchi G.
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):88-98. PubMed ID: 1383636
    [Abstract] [Full Text] [Related]

  • 12. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J.
    Circ Res; 2006 Sep 01; 99(5):528-36. PubMed ID: 16902180
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N, Dong P, Huang Q, Jin W, Zhang J, Dai Q, Liu S.
    Clin Exp Pharmacol Physiol; 2009 Mar 01; 36(3):262-6. PubMed ID: 18785976
    [Abstract] [Full Text] [Related]

  • 15. The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart.
    Roffe C, MacDiarmaid-Gordon A, Ohanian V, Hollis S, Heagerty AM.
    Cardiovasc Res; 1996 Jun 01; 31(6):907-16. PubMed ID: 8759246
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P, Shindo T, Iwata H, Iimuro S, Takeda N, Zhang Y, Ebihara A, Suematsu Y, Kangawa K, Hirata Y, Nagai R.
    Circulation; 2004 Apr 13; 109(14):1789-94. PubMed ID: 14967720
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):115-20. PubMed ID: 17157294
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice.
    Pellieux C, Montessuit C, Papageorgiou I, Pedrazzini T, Lerch R.
    Am J Physiol Heart Circ Physiol; 2012 May 01; 302(9):H1795-805. PubMed ID: 22408021
    [Abstract] [Full Text] [Related]

  • 19. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G, Li X, Hein DW, Xiang X, Marshall JP, Prabhu SD, Cai L.
    J Am Coll Cardiol; 2008 Aug 19; 52(8):655-66. PubMed ID: 18702970
    [Abstract] [Full Text] [Related]

  • 20. Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention.
    Huggins CE, Domenighetti AA, Ritchie ME, Khalil N, Favaloro JM, Proietto J, Smyth GK, Pepe S, Delbridge LM.
    J Mol Cell Cardiol; 2008 Feb 19; 44(2):270-80. PubMed ID: 18191142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.